Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase I Single and Multiple-Dose Safety and Pharmacokinetic Clinical S-261985081
University of Illinois at Chi
Search grants from University of Illinois at Chi
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Heterodimerization of CXCR4 and CB2 Inhibits Prostate Cancer Cell Movement
Smooth muscle cell integration of differentiation signals
Brain Molecular Anatomy Project: Gene Discovery
Genetic Studies of Adeno-Associated Virus
Equipment for Preparing Plastic Histologic Sections for an Undergraduate Light Microscopy Program.
Recently added grants:
New mechanisms for modulating the MALT1 oncoprotein
Repurposing systemic therapies to improve clinical outcomes in advanced basal cell cancer
Cul5 and Triad1 partner to prevent T cell mediated lung inflammation and asthma
Intra-Articular Delivery of Sustained Release NF-kB Antagonists in Arthritis
Role of Desmoglein 1 in Keratinocyte-Melanocyte Communication and Melanoma
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Prevention And Control (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN985081-003
Application #
7191436
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2005
Total Cost
Indirect Cost
Institution
Name
University of Illinois at Chi
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2006
N01 CN
Phase I Single and Multiple-Dose Safety and Pharmacokinetic Clinical S-261985081
/ University of Illinois at Chi
NIH 2005
N01 CN
Phase I Single and Multiple-Dose Safety and Pharmacokinetic Clinical S-261985081
/ University of Illinois at Chi
NIH 2004
N01 CN
Phase I Single and Multiple-Dose Safety and Pharmacokinetic Clinical S-261985081
/ University of Illinois at Chi
Comments
Be the first to comment on this grant